Claudia L. Nino-Charles

Sierra Mojada 950, CP 44340
Guadalajara, JAL 44340, Mexico

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Cytokine dysregulation and lymphopenia in dogs naturally infected with canine parvovirus type 2c.

Cytokine dysregulation and lymphopenia in dogs naturally infected with canine parvovirus type 2c.

Journal: Veterinary immunology and immunopathology

Published: November 26, 2025

Cryptococcus neoformans invasion of the orbital compartment and periocular spaces following intracerebral infection in mice.

Cryptococcus neoformans invasion of the orbital compartment and periocular spaces following intracerebral infection in mice.

Journal: iScience

Published: June 10, 2025

Active Cryptococcus neoformans glucuronoxylomannan production prevents elimination of cryptococcal CNS infection in vivo.

Active Cryptococcus neoformans glucuronoxylomannan production prevents elimination of cryptococcal CNS infection in vivo.

Journal: Journal of neuroinflammation

Published: October 16, 2024

Reduced growth and biofilm formation at high temperatures contribute to Cryptococcus deneoformans dermatotropism.

Reduced growth and biofilm formation at high temperatures contribute to Cryptococcus deneoformans dermatotropism.

Journal: Disease models & mechanisms

Published: October 08, 2024

IL-6 deficiency accelerates cerebral cryptococcosis and alters glial cell responses.

IL-6 deficiency accelerates cerebral cryptococcosis and alters glial cell responses.

Journal: Journal of neuroinflammation

Published: February 24, 2024

Species distribution and antifungal susceptibility profiles of clinical and environmental Fusarium isolates from Mexico: A multicenter study.

Species distribution and antifungal susceptibility profiles of clinical and environmental Fusarium isolates from Mexico: A multicenter study.

Journal: Mycologia

Published: January 17, 2024

Inhibition of RhoA Prevents Cryptococcus neoformans Capsule Glucuronoxylomannan-Stimulated Brain Endothelial Barrier Disruption.

Inhibition of RhoA Prevents Cryptococcus neoformans Capsule Glucuronoxylomannan-Stimulated Brain Endothelial Barrier Disruption.

Journal: The Journal of infectious diseases

Published: December 13, 2023

Palmitoylethanolamide shows limited efficacy in controlling cerebral cryptococcosis in vivo.

Palmitoylethanolamide shows limited efficacy in controlling cerebral cryptococcosis in vivo.

Journal: Antimicrobial agents and chemotherapy

Published: September 26, 2023

Palmitoylethanolamide shows limited efficacy in controlling cerebral cryptococcosis in vivo.

Palmitoylethanolamide shows limited efficacy in controlling cerebral cryptococcosis in vivo.

Journal: bioRxiv : the preprint server for biology

Published: April 24, 2023

Neurocognitive Psychiatric and Neuropsychological Alterations in Parkinson's Disease: A Basic and Clinical Approach.

Neurocognitive Psychiatric and Neuropsychological Alterations in Parkinson's Disease: A Basic and Clinical Approach.

Journal: Brain sciences

Published: February 14, 2023

Clinical and pathological characterization of Central Nervous System cryptococcosis in an experimental mouse model of stereotaxic intracerebral infection.

Clinical and pathological characterization of Central Nervous System cryptococcosis in an experimental mouse model of stereotaxic intracerebral infection.

Journal: PLoS neglected tropical diseases

Published: December 02, 2022

Glucuronoxylomannan intranasal challenge prior to Cryptococcus neoformans pulmonary infection enhances cerebral cryptococcosis in rodents.

Glucuronoxylomannan intranasal challenge prior to Cryptococcus neoformans pulmonary infection enhances cerebral cryptococcosis in rodents.

Journal: PLoS pathogens

Published: October 21, 2022

Showing 1-12 of 28

Last Updated: 09/26/2026